Literature DB >> 17962086

Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.

Jing Zhang1, Xi Guang Chen, Yan Yan Li, Cheng Sheng Liu.   

Abstract

In this study self-assembled nanoparticles based on oleoyl-chitosan (OCH) were prepared with a mean diameter of 255.3 nm and an almost spherical shape. The toxicity profile of OCH nanoparticles was evaluated in vitro via hemolysis test and MTT assay. The hemolysis rates of OCH nanoparticles tested in different conditions came well within permissible limits (5%). The OCH nanoparticles showed no cytotoxicity to mouse embryo fibroblasts. Doxorubicin (DOX) was efficiently loaded into OCH nanoparticles with an encapsulation efficiency of 52.6%. The drug was rapidly and completely released from the nanoparticles (DOX-OCH nanoparticles) at pH 3.8, whereas at pH 7.4 there was a sustained release after a burst release. The inhibitory rates of DOX-OCH nanoparticle suspension to different human cancer cells (A549, Bel-7402, HeLa, and SGC-7901) significantly outperformed that of DOX solution. These results revealed the potential of OCH nanoparticles as carriers for hydrophobic antitumor agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17962086     DOI: 10.1016/j.nano.2007.08.002

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  21 in total

Review 1.  Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers.

Authors:  Qingxing Xu; Chi-Hwa Wang; Daniel Wayne Pack
Journal:  Curr Pharm Des       Date:  2010-07       Impact factor: 3.116

Review 2.  Non-invasive administration of biodegradable nano-carrier vaccines.

Authors:  Mohd Abul Kalam; Abdul Arif Khan; Aws Alshamsan
Journal:  Am J Transl Res       Date:  2017-01-15       Impact factor: 4.060

3.  Triple Drug Combination of Zidovudine, Efavirenz and Lamivudine Loaded Lactoferrin Nanoparticles: an Effective Nano First-Line Regimen for HIV Therapy.

Authors:  Prashant Kumar; Yeruva Samrajya Lakshmi; Anand K Kondapi
Journal:  Pharm Res       Date:  2016-12-07       Impact factor: 4.200

4.  Preparation and evaluation of oleoyl-carboxymethy-chitosan (OCMCS) nanoparticles as oral protein carriers.

Authors:  Ya Liu; Xiao Jie Cheng; Qi Feng Dang; Fang Kui Ma; Xi Guang Chen; Hyun Jin Park; Bum Keun Kim
Journal:  J Mater Sci Mater Med       Date:  2011-12-03       Impact factor: 3.896

5.  Self-assembled polymeric nanoparticles based on oleic acid-grafted chitosan oligosaccharide: biocompatibility, protein adsorption and cellular uptake.

Authors:  Jing Zhang; Xi Guang Chen; Lu Huang; Jing Tian Han; Xiao Fan Zhang
Journal:  J Mater Sci Mater Med       Date:  2012-05-04       Impact factor: 3.896

6.  Investigation of polymeric amphiphilic nanoparticles as antitumor drug carriers.

Authors:  Jing Zhang; Xi Guang Chen; Cheng Sheng Liu; Hyun Jin Park
Journal:  J Mater Sci Mater Med       Date:  2008-12-13       Impact factor: 3.896

7.  Aqueous Compatible Fullerene-Doxorubicin Conjugates.

Authors:  Fushen Lu; Sk Anwarul Haque; Sheng-Tao Yang; Pengju G Luo; Lingrong Gu; Alex Kitaygorodskiy; Huaping Li; Sebastian Lacher; Ya-Ping Sun
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2009-10-15       Impact factor: 4.126

8.  Self-assembled chitosan-ceramide nanoparticle for enhanced oral delivery of paclitaxel.

Authors:  Gantumur Battogtokh; Young Tag Ko
Journal:  Pharm Res       Date:  2014-05-14       Impact factor: 4.200

9.  Efficacy, safety and anticancer activity of protein nanoparticle-based delivery of doxorubicin through intravenous administration in rats.

Authors:  Kishore Golla; Bhaskar Cherukuvada; Farhan Ahmed; Anand K Kondapi
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

10.  Application of the central composite design to optimize the preparation of novel micelles of harmine.

Authors:  Yong-Yan Bei; Xiao-Feng Zhou; Ben-Gang You; Zhi-Qiang Yuan; Wei-Liang Chen; Peng Xia; Yang Liu; Yong Jin; Xiao-Juan Hu; Qiao-Ling Zhu; Chun-Ge Zhang; Xue-Nong Zhang; Liang Zhang
Journal:  Int J Nanomedicine       Date:  2013-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.